Drug profile · INN
alpha1-proteinase inhibitor (human)
RESPREEZA
alpha1-proteinase inhibitor (human) (RESPREEZA) is a leukocyte elastase inhibitor.
EMA: approved Blood and blood forming organs (B02) B02AB02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — alpha1-proteinase inhibitor (human)
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
alpha1-proteinase inhibitor (human) (RESPREEZA) is a leukocyte elastase inhibitor.
Key facts
INN alpha1-proteinase inhibitor (human)
Brand RESPREEZA
Mechanism Leukocyte elastase inhibitor
Target Neutrophil elastase
Therapeutic class Blood and blood forming organs (B02)
ATC code B02AB02
Mechanism of action
Leukocyte elastase inhibitor
Primary target: Neutrophil elastase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is alpha1-proteinase inhibitor (human)?
alpha1-proteinase inhibitor (human) (RESPREEZA) is a leukocyte elastase inhibitor.
What is the brand name for alpha1-proteinase inhibitor (human)?
RESPREEZA is a marketed brand name for alpha1-proteinase inhibitor (human). Check FDA Drugs@FDA for the current US label holder and prescribing information.